Sun Pharma brings in Akshay Kumar to pitch for Revital H Sun Pharma brings in Akshay Kumar to pitch for Revital H Apurva Joshi / Monday, July 9, 2018 / Article rating: 3.0 Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Limited has announced that is has signed Bollywood star Akshay Kumar as the new brand ambassador of Revital H.
Mutual Fund Update: Domestic MF AUM at 22.86 lakh crore in June 2018 Mutual Fund Update: Domestic MF AUM at 22.86 lakh crore in June 2018 Shashikant Singh / Monday, July 9, 2018 / Article rating: 5.0 Increase in the inflows to liquid funds saved the day for domestic MF inflows even as equity funds continued to show lower inflows.
Kirloskar Pneumatic up 8 per cent as board considers stock split Kirloskar Pneumatic up 8 per cent as board considers stock split Shohini Nath / Monday, July 9, 2018 / Article rating: 5.0 Kirloskar Pneumatic rose by 8 per cent on Monday after the company announced that its board is considering a stock split.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Monday, July 9, 2018 / Article rating: 3.0 Following stocks are close to their 52-week low as at 12.58 p.m. on July 9, 2018.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Monday, July 9, 2018 / Article rating: 5.0 The markets on July 9, 2018 opened gap up. BSE Sensex is trading at 35,887.99, up by 230.13 points and the Nifty is trading at 10,838.60, up by 65.95 points.
NCLT rules in favour of Tata Sons; Tata group stocks up NCLT rules in favour of Tata Sons; Tata group stocks up Tanay Loya / Monday, July 9, 2018 / Article rating: 3.7 The National Company Law Tribunal on Monday, ruled in favour of Tata Sons against Cyrus Mistry's plea challenging his removal as Tata Sons' Chairman.
DB Corp ascends post share buyback approval DB Corp ascends post share buyback approval Tanay Loya / Monday, July 9, 2018 / Article rating: 3.5 Shares of Media firm DB Corp gained over 7 per cent on Monday after the company’s shareholders approved Rs. 312 .8 crore share buyback proposal.
Cadila Healthcare gains on tentative approval for Deferasirox tablets Cadila Healthcare gains on tentative approval for Deferasirox tablets Shohini Nath / Monday, July 9, 2018 / Article rating: 5.0 Zydus Cadila Healthcare Limited received a tentative approval from USFDA for oral suspension Deferasirox (Exjade) tablets in the strengths of 125 mg, 250 mg and 500 mg to treat high levels of iron in the body. The stock gained 2 per cent on Monday.
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Monday, July 9, 2018 / Article rating: 5.0 Overall volumes in futures & options currently stand at 51.77 lakh contracts with a turnover of Rs. 4,56,642.98 crore.
Five stocks with buying interest Five stocks with buying interest Shital Jibhe / Monday, July 9, 2018 / Article rating: 4.3 Overall volumes in futures & options currently stand at 51.77 lakh contracts with a turnover of Rs. 4,56,642.98 crore.